SCHEMBL23577635

SCHEMBL23577635

CCOC(=O)c1cc2c(cc1N)oc(=O)n2C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ GAA P10253 3/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ TP53 P04637 3/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ BAZ2B Q9UIF8 1/20 0.40
▸ BAZ2A Q9UIF9 1/20 0.40
▸ MAOB P27338 2/20 0.40
▸ MIF P14174 1/20 0.40
▸ PFKFB3 Q16875 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ CA12 O43570 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA3 P07451 2/20 0.38
▸ CA4 P22748 2/20 0.38
▸ CA6 P23280 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30183917 1.00 LMNA (0.47) LMNAALDH1A1GAAKDM4EHPGD
SCHEMBL23577953 0.84 LMNA (0.47) LMNAALDH1A1GAAKDM4EHPGD
SCHEMBL30183695 0.84 LMNA (0.47) LMNAALDH1A1GAAKDM4EHPGD
SCHEMBL23590714 0.80 ALDH1A1 (0.57) LMNAALDH1A1GAAKDM4EHPGD
Hydrochloric Acid SCHEMBL30183881 0.79 ALDH1A1 (0.56) LMNAALDH1A1GAAKDM4EHPGD
Hydrochloric Acid SCHEMBL23578406 0.79 ALDH1A1 (0.56) LMNAALDH1A1GAAKDM4EHPGD
SCHEMBL30184079 0.76 LMNA (0.43) LMNAALDH1A1KDM4EHPGDTP53
SCHEMBL23577752 0.76 LMNA (0.43) LMNAALDH1A1KDM4EHPGDTP53
SCHEMBL24885170 0.75 LMNA (0.47) LMNAALDH1A1KDM4ETP53MAPK1
SCHEMBL7471868 0.74 ALDH1A1 (0.63) LMNAALDH1A1GAAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081521-B1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LTD (IN) 2025-12-10 — — EP disclosed
CN-115605476-B Substituted tricyclic compounds 鲁宾有限公司 2024-05-24 — — CN disclosed
US-20230119316-A1 Substituted Tricyclic Compounds LUPIN LIMITED (IN) 2023-04-20 — — US disclosed
CN-115605476-A Substituted tricyclic compounds 鲁宾有限公司(IN) 2023-01-13 — — CN disclosed
EP-4081521-A1 SUBSTITUTED TRICYCLIC COMPOUNDS Lupin Limited (IN) 2022-11-02 — — EP disclosed
WO-2021130731-A1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LIMITED (IN) 2021-07-01 — — WO disclosed
WO-2021130731-A1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LIMITED (IN) 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230119316-A1 Substituted Tricyclic Compounds SOS1, RSU1, KSR1 LMNA 1729/4885ALDH1A1 3322/4885GAA 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback